SCHEMBL19564264

SCHEMBL19564264

Cc1ccc(N(c2ccccc2)c2ccc3cc4c5cc(-c6ccccc6)cc6c7cc8ccc(N(c9ccccc9)c9ccc(C)cc9C)cc8cc7n(c4cc3c2)c56)c(C)c1

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 1/20 0.30
▸ TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19564328 0.92 — —
SCHEMBL19564260 0.92 CYP2A6 (0.30) CYP2A6TDP1
SCHEMBL19564197 0.90 CYP2A6 (0.32) CYP2A6TDP1
SCHEMBL19564257 0.90 — —
SCHEMBL19564269 0.90 CYP2A6 (0.30) CYP2A6TDP1
SCHEMBL19564263 0.89 HTT (0.32) CYP2A6TDP1
SCHEMBL19564258 0.88 HTT (0.33) CYP2A6TDP1
SCHEMBL19564254 0.87 MAPT (0.32) TDP1
SCHEMBL19564277 0.86 — —
SCHEMBL19564089 0.85 KDM4E (0.31) TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11723272-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-08-08 — — US disclosed
US-11723272-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-08-08 — — US disclosed
US-20200365812-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2020-11-19 — — US disclosed
US-20190097142-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2019-03-28 — — US disclosed
US-10230058-B2 Compound, organic electroluminescence device and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2019-03-12 — — US disclosed
US-20180198076-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-12 — — US disclosed
US-20180198076-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-12 — — US disclosed
US-9954187-B2 Compound, organic electroluminescence device and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2018-04-24 — — US disclosed
US-9954187-B2 Compound, organic electroluminescence device and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2018-04-24 — — US disclosed
US-20170324045-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-11-09 — — US disclosed
US-20170324045-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-11-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190097142-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE LEF1, L1CAM, EMC1 CYP2A6 1737/4885TDP1 2143/4885
US-20180198076-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE LEF1, L1CAM, EMC1 CYP2A6 1737/4885TDP1 2143/4885
US-20170324045-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE LEF1, L1CAM, EMC1 CYP2A6 1737/4885TDP1 2143/4885
US-10230058-B2 Compound, organic electroluminescence device and electronic device LEF1, L1CAM, EMC1 CYP2A6 1737/4885TDP1 2143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback